AMP Poster 2019
Utility of Biomarkers to Differentiate Adenocarcinoma Of The Uterine Cervix from Its Mimics
November 12, 2019
Never Miss an Update
Sign up and receive Discovery updates, blogs, and market news directly to your inbox.
Subscribe NowIntroduction:
- Endometrial adenocarcinoma invading the endocervix is histologically equivalent to cervical adenocarcinoma
- Several benign conditions of the cervix can mimic adenocarcinoma
- Cervical adenocarcinoma requires HPV infection; endometrial cancer is HPV negative
- Thus, we interrogated several biomarkers associated with HPV infection to determine if they could differentiate endocervical from endometrial adenocarcinoma
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
